- Home
- GEHC vs A Comparison
GEHC vs A Comparison
Compare GEHC & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEHC
- A
- Stock Information
- Founded
- GEHC 1892
- A 1999
- Country
- GEHC United States
- A United States
- Employees
- GEHC N/A
- A N/A
- Industry
- GEHC Computer Software: Prepackaged Software
- A Biotechnology: Laboratory Analytical Instruments
- Sector
- GEHC Technology
- A Industrials
- Exchange
- GEHC Nasdaq
- A Nasdaq
- Market Cap
- GEHC 40.4B
- A 37.5B
- IPO Year
- GEHC N/A
- A 1999
- Fundamental
- Price
- GEHC $82.26
- A $131.58
- Analyst Decision
- GEHC Buy
- A Buy
- Analyst Count
- GEHC 14
- A 17
- Target Price
- GEHC $94.36
- A $143.07
- AVG Volume (30 Days)
- GEHC 3.5M
- A 1.9M
- Earning Date
- GEHC 10-30-2024
- A 11-25-2024
- Dividend Yield
- GEHC 0.14%
- A 0.74%
- EPS Growth
- GEHC 8.27
- A 25.91
- EPS
- GEHC 3.65
- A 4.81
- Revenue
- GEHC $19,559,000,000.00
- A $6,497,000,000.00
- Revenue This Year
- GEHC $2.77
- A N/A
- Revenue Next Year
- GEHC $4.14
- A $5.30
- P/E Ratio
- GEHC $23.24
- A $26.71
- Revenue Growth
- GEHC 1.43
- A N/A
- 52 Week Low
- GEHC $66.39
- A $123.48
- 52 Week High
- GEHC $94.55
- A $155.35
- Technical
- Relative Strength Index (RSI)
- GEHC 44.48
- A 42.88
- Support Level
- GEHC $81.71
- A $124.89
- Resistance Level
- GEHC $85.29
- A $143.07
- Average True Range (ATR)
- GEHC 2.07
- A 3.33
- MACD
- GEHC -0.10
- A -0.48
- Stochastic Oscillator
- GEHC 37.38
- A 29.46
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).
About A Agilent Technologies Inc.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.